Excipients—the inactive ingredients that give drugs their stability, delivery precision, and patient-friendliness—are having a quiet but consequential moment. As pharmaceutical companies race to launch biologics, cell and gene therapies, and personalized dosage forms, the humble excipient has become a genuine differentiator rather than an afterthought in formulation science....
The biopharmaceutical excipients market is poised for transformative changes as it approaches an estimated value of USD 12.4 billion by 2035. With a compound annual growth rate (CAGR) of 5.09%, the sector demonstrates robust potential amidst an evolving healthcare landscape. Emerging innovations in drug formulation are driving this growth, as stakeholders strive to meet the demands of the...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek